Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples